Terms: = Kidney tumors AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
1498 results:
1. Renal and major clinical outcomes and their determinants after nephrectomy in patients with pre-existing chronic kidney disease: A retrospective cohort study.
Schleef M; Roy P; Lemoine S; Paparel P; Colombel M; Badet L; Guebre-Egziabher F
PLoS One; 2024; 19(5):e0300367. PubMed ID: 38696458
[TBL] [Abstract] [Full Text] [Related]
2. Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
Yang JD; Liu YC; Wang HC; Hsu FT; Liao TL; Huang MC; Chen JH
In Vivo; 2024; 38(3):1079-1093. PubMed ID: 38688627
[TBL] [Abstract] [Full Text] [Related]
3. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
[TBL] [Abstract] [Full Text] [Related]
4. Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor.
Ying JM; Yan F
Iran J Kidney Dis; 2024 Mar; 18(2):108-117. PubMed ID: 38660695
[TBL] [Abstract] [Full Text] [Related]
5. Clinical safety and efficacy of microwave ablation for small renal masses.
Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
[TBL] [Abstract] [Full Text] [Related]
6. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study).
Beauval JB; Khene ZE; Roumiguié M; Rahota R; Mejean A; Doumerc N; Roupret M; Paparel P; Villers A; Bruyere F; Lebacle C; Nouhaud FX; Champy C; de la Taille A; Lang H; Rizk J; Durand M; Dariane C; Charles T; Boissier R; Long JA; Bigot P; Bensalah K; Bernhard JC
World J Urol; 2024 Apr; 42(1):213. PubMed ID: 38581466
[TBL] [Abstract] [Full Text] [Related]
7. Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying egfr.
Spinelli C; Adnani L; Meehan B; Montermini L; Huang S; Kim M; Nishimura T; Croul SE; Nakano I; Riazalhosseini Y; Rak J
Nat Commun; 2024 Apr; 15(1):2865. PubMed ID: 38570528
[TBL] [Abstract] [Full Text] [Related]
8. Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.
Sengul N; Gültürk I; Yilmaz M; Celik E; Paksoy N; Yekedüz E; Ürün Y; Basaran M; Özgüroğlu M
Actas Urol Esp (Engl Ed); 2024 May; 48(4):273-280. PubMed ID: 38570033
[TBL] [Abstract] [Full Text] [Related]
9. Predictive factors of renal function after robot-assisted partial nephrectomy in clinical T1b tumors.
Yamamoto R; Numakura K; Kobayashi M; Nara T; Saito M; Narita S; Habuchi T
J Robot Surg; 2024 Apr; 18(1):154. PubMed ID: 38564051
[TBL] [Abstract] [Full Text] [Related]
10. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased egfr expression by activating AhR and Akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.
Saitta C; Garofano G; Lughezzani G; Meagher MF; Yuen KL; Fasulo V; Diana P; Uleri A; Piccolini A; Mancon S; Arena P; Sordelli F; Mantovani M; Avolio PP; Beatrici E; Hurle RF; Lazzeri M; Saita A; Casale P; Derweesh IH; Paciotti M; Buffi NM
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541189
[No Abstract] [Full Text] [Related]
13. Machine learning models for predicting the onset of chronic kidney disease after surgery in patients with renal cell carcinoma.
Oh SW; Byun SS; Kim JK; Jeong CW; Kwak C; Hwang EC; Kang SH; Chung J; Kim YJ; Ha YS; Hong SH
BMC Med Inform Decis Mak; 2024 Mar; 24(1):85. PubMed ID: 38519947
[TBL] [Abstract] [Full Text] [Related]
14. Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
Kollerits B; Gruber S; Steinbrenner I; Schwaiger JP; Weissensteiner H; Schönherr S; Forer L; Kotsis F; Schultheiss UT; Meiselbach H; Wanner C; Eckardt KU; Kronenberg F;
BMC Cancer; 2024 Mar; 24(1):320. PubMed ID: 38454416
[TBL] [Abstract] [Full Text] [Related]
15. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight.
Damare R; Engle K; Kumar G
Phytother Res; 2024 May; 38(5):2406-2447. PubMed ID: 38433568
[TBL] [Abstract] [Full Text] [Related]
16. Centrality angle is a novel nephrometry score to predict tumor complexity and perioperative outcomes for partial nephrectomy.
Miyamoto S; Goto K; Tasaka R; Kohada Y; Fukushima T; Takemoto K; Babasaki T; Kobatake K; Sekino Y; Kitano H; Ikeda K; Hieda K; Hayashi T; Hinata N
Sci Rep; 2024 Feb; 14(1):4780. PubMed ID: 38413713
[TBL] [Abstract] [Full Text] [Related]
17. Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer.
Rinaldi L; Chiuso F; Senatore E; Borzacchiello D; Lignitto L; Iannucci R; Donne RD; Fuggi M; Reale C; Russo F; Russo NA; Giurato G; Rizzo F; Sellitto A; Santangelo M; De Biase D; Paciello O; D'Ambrosio C; Amente S; Garbi C; Dalla E; Scaloni A; Weisz A; Ambrosino C; Insabato L; Feliciello A
Commun Biol; 2024 Feb; 7(1):208. PubMed ID: 38379085
[TBL] [Abstract] [Full Text] [Related]
18. Single-port vs multi-port robot-assisted partial nephrectomy: A single center propensity score-matched analysis.
Licari LC; Bologna E; Franco A; Ditonno F; Manfredi C; Huang J; Latchamsetty K; Coogan C; Olweny EO; Cherullo EE; Chow AK; Vourganti S; Autorino R
Eur J Surg Oncol; 2024 Mar; 50(3):108011. PubMed ID: 38359726
[TBL] [Abstract] [Full Text] [Related]
19. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
[TBL] [Abstract] [Full Text] [Related]
20. Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.
Ali M; Koo K; Chang D; Chan P; Oon SF; Moon D; Murphy DG; Eapen R; Goad J; Lawrentschuk N; Azad AA; Chander S; Shaw M; Hardcastle N; Siva S
Radiat Oncol; 2024 Feb; 19(1):23. PubMed ID: 38355495
[TBL] [Abstract] [Full Text] [Related]
[Next]
